Hutchmed (China)'a Cancer Drug Phase I Clinical Trial Begins
Hutchmed (China)'a Cancer Drug Phase I Clinical Trial Begins
鳳凰新聞報道,起始於4月20日,哈藥集團生產的新冠疫苗開始在國內接種。其中BBIBP-CorV是一款人體滅活疫苗,而Healive是一款重組亞單位疫苗。目前,已有超過260萬人接種新冠疫苗,相關數據監測結果良好。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。